Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Monday broker round-up

Mon, 24th Aug 2020 10:57
(Sharecast News) - Dechra Pharmaceuticals: Liberum initiates at sell with a target price of 2,740p.



Smith & Nephew: JP Morgan reiterates neutral with a target price of 1,553p.

Victrex: Barclays reiterates neutral with a target price of 1,680p.

Network International: Barclays reiterates overweight with a target price of 450p.

Ocado: Citigroup reiterates buy with a target price of 2,900p.

BT: Citigroup reiterates neutral with a target price of 110p.

Just Group: RBC Capital Markets reiterates outperform with a target price of 130p.

CVS: Liberum initiates hold with a target price of 1,274p.

Frasers Group: Peel Hunt reiterates hold with a target price of 325p.

Related News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
2 days ago

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

IN BRIEF: Smith & Nephew completes first CORI platform clinical cases
2 days ago

IN BRIEF: Smith & Nephew completes first CORI platform clinical cases

Smith & Nephew PLC - Watford, England-based medical devices maker - Announces the completion of the first clinical cases performed using the next gene...

BTG Consulting buys liquidation services firm MVLOnline
5 Jun 2026

BTG Consulting buys liquidation services firm MVLOnline

(Alliance News) - BTG Consulting PLC on Friday said it has acquired liquidations website MVLOnline.co.uk.

DPH.L News

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra
12 Jan 2024

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra

Persimmon PLC - York, England-based housebuilder - To rejoin FTSE 100 index on Tuesday as acquisition of Cheshire, England-based veterinary drug maker...

IN BRIEF: EU clears Dechra Pharmaceuticals takeover by EQT funds
27 Dec 2023

IN BRIEF: EU clears Dechra Pharmaceuticals takeover by EQT funds

Dechra Pharmaceuticals PLC - Cheshire, England-based veterinary drug maker - European Commission on Friday clears takeover of Dechra by funds managed ...

IN BRIEF: Hargreaves Lansdown picks Dechra chair Alison Platt as chair
29 Nov 2023

IN BRIEF: Hargreaves Lansdown picks Dechra chair Alison Platt as chair

Hargreaves Lansdown PLC - Bristol, England-based wealth management platform - Hires Alison Platt, the current chair of Dechra Pharmaceuticals PLC, to ...

LONDON MARKET OPEN: FTSE 100 falls; Halfords, Xaar plunge
29 Nov 2023

LONDON MARKET OPEN: FTSE 100 falls; Halfords, Xaar plunge

(Alliance News) - Stock prices in London opened mixed on Wednesday, as large caps fell on account of a stronger pound, though the domestically-focused...

LONDON BRIEFING: Hargreaves Lansdown says Dechra's Platt to be chair
29 Nov 2023

LONDON BRIEFING: Hargreaves Lansdown says Dechra's Platt to be chair

(Alliance News) - Stocks in London are expected to open lower on Wednesday, as investors consider the latest dovish remarks from the US Federal Reserv...

Dechra Pharmaceuticals director steps down after 12 years
27 Nov 2023

Dechra Pharmaceuticals director steps down after 12 years

(Alliance News) - Dechra Pharmaceuticals PLC on Monday said Director Tony Griffin has stepped down after 12 years in the role, effective immediately.

Tony Griffin stepping down as Dechra executive director
27 Nov 2023

Tony Griffin stepping down as Dechra executive director

(Sharecast News) - Dechra Pharmaceuticals announced the departure of one of its longstanding executives, Tony Griffin, on Monday.